We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
Most cancer tissues displayed moderate nuclear positivity. Strong staining was observed in a few cases of gastric and liver cancers. Several malignant gliomas, lymphomas and renal cancers were weakly stained or negative.
Head and neck cancers, thyroid cancers, several cases of urothelial, pancreatic, colorectal and breast cancers along with few cases of squamous cell carcinoma, melanoma, testis, prostate cancers displayed weak to moderate nuclear staining. Few cases of colorectal cancers showed additional membranous immunoreactivity. Remaining cancer tissues were weakly stained or negative.
This gene encodes a protein that mediates ligand-independent transcription repression of thyroid-hormone and retinoic-acid receptors by promoting chromatin condensation and preventing access of the transcription machinery. It is part of a complex which also includes histone deacetylases and transcriptional regulators similar to the yeast protein Sin3p. This gene is located between the Charcot-Marie-Tooth and Smith-Magenis syndrome critical regions on chromosome 17. Alternate splicing results in multiple transcript variants. Pseudogenes of this gene are found on chromosomes 17 and 20.[provided by RefSeq, Jun 2010]
Predicted intracellular proteins Plasma proteins Transcription factors Helix-turn-helix domains Cancer-related genes Mutated cancer genes Mutational cancer driver genes COSMIC somatic mutations in cancer genes COSMIC Somatic Mutations COSMIC Other Mutations COSMIC Nonsense Mutations COSMIC Missense Mutations COSMIC Frameshift Mutations Protein evidence (Kim et al 2014) Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000118 [histone deacetylase complex] GO:0000122 [negative regulation of transcription from RNA polymerase II promoter] GO:0000790 [nuclear chromatin] GO:0001012 [RNA polymerase II regulatory region DNA binding] GO:0001102 [RNA polymerase II activating transcription factor binding] GO:0002155 [regulation of thyroid hormone mediated signaling pathway] GO:0002361 [CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation] GO:0003677 [DNA binding] GO:0003682 [chromatin binding] GO:0003700 [transcription factor activity, sequence-specific DNA binding] GO:0003714 [transcription corepressor activity] GO:0005515 [protein binding] GO:0005634 [nucleus] GO:0005654 [nucleoplasm] GO:0005667 [transcription factor complex] GO:0005737 [cytoplasm] GO:0005876 [spindle microtubule] GO:0006325 [chromatin organization] GO:0006351 [transcription, DNA-templated] GO:0006357 [regulation of transcription from RNA polymerase II promoter] GO:0006366 [transcription from RNA polymerase II promoter] GO:0006367 [transcription initiation from RNA polymerase II promoter] GO:0007179 [transforming growth factor beta receptor signaling pathway] GO:0007219 [Notch signaling pathway] GO:0007519 [skeletal muscle tissue development] GO:0007595 [lactation] GO:0007623 [circadian rhythm] GO:0008284 [positive regulation of cell proliferation] GO:0010467 [gene expression] GO:0010629 [negative regulation of gene expression] GO:0014067 [negative regulation of phosphatidylinositol 3-kinase signaling] GO:0016020 [membrane] GO:0016568 [chromatin modification] GO:0016580 [Sin3 complex] GO:0016922 [ligand-dependent nuclear receptor binding] GO:0017053 [transcriptional repressor complex] GO:0019904 [protein domain specific binding] GO:0021549 [cerebellum development] GO:0021794 [thalamus development] GO:0030331 [estrogen receptor binding] GO:0031065 [positive regulation of histone deacetylation] GO:0032922 [circadian regulation of gene expression] GO:0035033 [histone deacetylase regulator activity] GO:0035257 [nuclear hormone receptor binding] GO:0040014 [regulation of multicellular organism growth] GO:0042632 [cholesterol homeostasis] GO:0042826 [histone deacetylase binding] GO:0042974 [retinoic acid receptor binding] GO:0042975 [peroxisome proliferator activated receptor binding] GO:0043565 [sequence-specific DNA binding] GO:0044212 [transcription regulatory region DNA binding] GO:0044255 [cellular lipid metabolic process] GO:0044281 [small molecule metabolic process] GO:0045892 [negative regulation of transcription, DNA-templated] GO:0046329 [negative regulation of JNK cascade] GO:0046965 [retinoid X receptor binding] GO:0046966 [thyroid hormone receptor binding] GO:0048471 [perinuclear region of cytoplasm] GO:0051225 [spindle assembly] GO:0060318 [definitive erythrocyte differentiation] GO:0072362 [regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter] GO:0072368 [regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter] GO:1904017 [cellular response to Thyroglobulin triiodothyronine] GO:2000191 [regulation of fatty acid transport]
Predicted intracellular proteins Cancer-related genes Mutated cancer genes Mutational cancer driver genes COSMIC somatic mutations in cancer genes COSMIC Somatic Mutations COSMIC Other Mutations COSMIC Nonsense Mutations COSMIC Missense Mutations COSMIC Frameshift Mutations Protein evidence (Ezkurdia et al 2014)
Predicted intracellular proteins Plasma proteins Transcription factors Helix-turn-helix domains Cancer-related genes Mutated cancer genes Mutational cancer driver genes COSMIC somatic mutations in cancer genes COSMIC Somatic Mutations COSMIC Other Mutations COSMIC Nonsense Mutations COSMIC Missense Mutations COSMIC Frameshift Mutations Protein evidence (Kim et al 2014) Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000118 [histone deacetylase complex] GO:0000122 [negative regulation of transcription from RNA polymerase II promoter] GO:0000790 [nuclear chromatin] GO:0001102 [RNA polymerase II activating transcription factor binding] GO:0003677 [DNA binding] GO:0003714 [transcription corepressor activity] GO:0005515 [protein binding] GO:0005634 [nucleus] GO:0005654 [nucleoplasm] GO:0005876 [spindle microtubule] GO:0006325 [chromatin organization] GO:0006351 [transcription, DNA-templated] GO:0006366 [transcription from RNA polymerase II promoter] GO:0006367 [transcription initiation from RNA polymerase II promoter] GO:0007179 [transforming growth factor beta receptor signaling pathway] GO:0007219 [Notch signaling pathway] GO:0007623 [circadian rhythm] GO:0010467 [gene expression] GO:0016020 [membrane] GO:0016568 [chromatin modification] GO:0016580 [Sin3 complex] GO:0016922 [ligand-dependent nuclear receptor binding] GO:0017053 [transcriptional repressor complex] GO:0035257 [nuclear hormone receptor binding] GO:0042826 [histone deacetylase binding] GO:0044212 [transcription regulatory region DNA binding] GO:0044255 [cellular lipid metabolic process] GO:0044281 [small molecule metabolic process] GO:0046329 [negative regulation of JNK cascade] GO:0046966 [thyroid hormone receptor binding] GO:0051225 [spindle assembly] GO:0072362 [regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter] GO:0072368 [regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter] GO:2000191 [regulation of fatty acid transport]
Predicted intracellular proteins Cancer-related genes Mutated cancer genes Mutational cancer driver genes COSMIC somatic mutations in cancer genes COSMIC Somatic Mutations COSMIC Other Mutations COSMIC Nonsense Mutations COSMIC Missense Mutations COSMIC Frameshift Mutations Protein evidence (Ezkurdia et al 2014)
Predicted intracellular proteins Plasma proteins Transcription factors Helix-turn-helix domains Cancer-related genes Mutated cancer genes Mutational cancer driver genes COSMIC somatic mutations in cancer genes COSMIC Somatic Mutations COSMIC Other Mutations COSMIC Nonsense Mutations COSMIC Missense Mutations COSMIC Frameshift Mutations Protein evidence (Kim et al 2014) Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000118 [histone deacetylase complex] GO:0000122 [negative regulation of transcription from RNA polymerase II promoter] GO:0000790 [nuclear chromatin] GO:0001102 [RNA polymerase II activating transcription factor binding] GO:0003677 [DNA binding] GO:0003714 [transcription corepressor activity] GO:0005515 [protein binding] GO:0005634 [nucleus] GO:0005654 [nucleoplasm] GO:0005876 [spindle microtubule] GO:0006325 [chromatin organization] GO:0006351 [transcription, DNA-templated] GO:0006366 [transcription from RNA polymerase II promoter] GO:0006367 [transcription initiation from RNA polymerase II promoter] GO:0007179 [transforming growth factor beta receptor signaling pathway] GO:0007219 [Notch signaling pathway] GO:0007623 [circadian rhythm] GO:0010467 [gene expression] GO:0016020 [membrane] GO:0016568 [chromatin modification] GO:0016580 [Sin3 complex] GO:0016922 [ligand-dependent nuclear receptor binding] GO:0017053 [transcriptional repressor complex] GO:0035257 [nuclear hormone receptor binding] GO:0042826 [histone deacetylase binding] GO:0044212 [transcription regulatory region DNA binding] GO:0044255 [cellular lipid metabolic process] GO:0044281 [small molecule metabolic process] GO:0046329 [negative regulation of JNK cascade] GO:0046966 [thyroid hormone receptor binding] GO:0051225 [spindle assembly] GO:0072362 [regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter] GO:0072368 [regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter] GO:2000191 [regulation of fatty acid transport]
Predicted intracellular proteins Cancer-related genes Mutated cancer genes Mutational cancer driver genes COSMIC somatic mutations in cancer genes COSMIC Somatic Mutations COSMIC Other Mutations COSMIC Nonsense Mutations COSMIC Missense Mutations COSMIC Frameshift Mutations Protein evidence (Ezkurdia et al 2014)
Predicted intracellular proteins Cancer-related genes Mutated cancer genes Mutational cancer driver genes COSMIC somatic mutations in cancer genes COSMIC Somatic Mutations COSMIC Other Mutations COSMIC Nonsense Mutations COSMIC Missense Mutations COSMIC Frameshift Mutations Protein evidence (Ezkurdia et al 2014)
Predicted intracellular proteins Cancer-related genes Mutated cancer genes Mutational cancer driver genes COSMIC somatic mutations in cancer genes COSMIC Somatic Mutations COSMIC Other Mutations COSMIC Nonsense Mutations COSMIC Missense Mutations COSMIC Frameshift Mutations Protein evidence (Ezkurdia et al 2014)
Predicted intracellular proteins Cancer-related genes Mutated cancer genes Mutational cancer driver genes COSMIC somatic mutations in cancer genes COSMIC Somatic Mutations COSMIC Other Mutations COSMIC Nonsense Mutations COSMIC Missense Mutations COSMIC Frameshift Mutations Protein evidence (Ezkurdia et al 2014)
Predicted intracellular proteins Cancer-related genes Mutated cancer genes Mutational cancer driver genes COSMIC somatic mutations in cancer genes COSMIC Somatic Mutations COSMIC Other Mutations COSMIC Nonsense Mutations COSMIC Missense Mutations COSMIC Frameshift Mutations Protein evidence (Ezkurdia et al 2014)
Predicted intracellular proteins Cancer-related genes Mutated cancer genes Mutational cancer driver genes COSMIC somatic mutations in cancer genes COSMIC Somatic Mutations COSMIC Other Mutations COSMIC Nonsense Mutations COSMIC Missense Mutations COSMIC Frameshift Mutations Protein evidence (Ezkurdia et al 2014)
Predicted intracellular proteins Cancer-related genes Mutated cancer genes Mutational cancer driver genes COSMIC somatic mutations in cancer genes COSMIC Somatic Mutations COSMIC Other Mutations COSMIC Nonsense Mutations COSMIC Missense Mutations COSMIC Frameshift Mutations Protein evidence (Ezkurdia et al 2014)
Predicted intracellular proteins Cancer-related genes Mutated cancer genes Mutational cancer driver genes COSMIC somatic mutations in cancer genes COSMIC Somatic Mutations COSMIC Other Mutations COSMIC Nonsense Mutations COSMIC Missense Mutations COSMIC Frameshift Mutations Protein evidence (Ezkurdia et al 2014)